Barclays Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $45
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice TargetHot
Barclays analyst Christopher Pasquale maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $48 to $45.
Barclays analyst Christopher Pasquale maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $48 to $45.